Introduction: A clear picture of neonatal withdrawal signs due to in utero selective serotonin reuptake inhibitor (SSRI) exposure and its consequences is still missing. Objective: A systematic review and a meta-analysis were performed to provide an overview of neonatal withdrawal signs following late in utero exposure to SSRIs and to quantify the corresponding risks. Methods: MEDLINE, Web of Science, and Embase were searched from inception to January 2021. The Meta-Analysis of Observational Studies in Epidemiology (MOOSE) guidelines were followed. English-language observational studies reporting on acute postpartum outcomes following late in utero exposure to SSRIs or SSRIs/venlafaxine were evaluated. Results: Of 2,269 citations reviewed, 79 studies were assessed for eligibility; 13 were included in the qualitative analysis of the literature, which allowed us to identify 26 signs. A meta-analysis was run separately for studies on SSRI exposure (n = 3) and those on SSRI/venlafaxine exposure (n = 6). Hypoglycemia was identified as a withdrawal sign based on the SSRI studies. Tremors, hypotonia, tachycardia, rapid breathing, respiratory distress, and hypertonia were identified as withdrawal signs based on the SSRI/venlafaxine studies. Conclusions: The present work provides a framework for the identification of neonatal SSRI withdrawal syndrome. Tapering and discontinuation of antidepressant drugs before and during the early phase of pregnancy are worth attempting to prevent the occurrence of this syndrome.

1.
Fava
GA
,
Gatti
A
,
Belaise
C
,
Guidi
J
,
Offidani
E
.
Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review
.
Psychother Psychosom
.
2015
;
84
(
2
):
72
81
.
[PubMed]
0033-3190
2.
Offidani
E
,
Fava
GA
,
Sonino
N
.
Iatrogenic comorbidity in childhood and adolescence: new insights from the use of antidepressant drugs
.
CNS Drugs
.
2014
Sep
;
28
(
9
):
769
74
.
[PubMed]
1172-7047
3.
Chouinard
G
,
Chouinard
VA
.
New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal
.
Psychother Psychosom
.
2015
;
84
(
2
):
63
71
.
[PubMed]
0033-3190
4.
Cosci
F
,
Chouinard
G
.
Acute and persistent withdrawal syndromes following discontinuation of psychotropic medications
.
Psychother Psychosom
.
2020
;
89
(
5
):
283
306
.
[PubMed]
0033-3190
5.
Ter Horst
PG
,
Jansman
FG
,
van Lingen
RA
,
Smit
JP
,
de Jong-van den Berg
LT
,
Brouwers
JR
.
Pharmacological aspects of neonatal antidepressant withdrawal
.
Obstet Gynecol Surv
.
2008
Apr
;
63
(
4
):
267
79
.
[PubMed]
0029-7828
6.
Tak
CR
,
Job
KM
,
Schoen-Gentry
K
,
Campbell
SC
,
Carroll
P
,
Costantine
M
, et al.
The impact of exposure to antidepressant medications during pregnancy on neonatal outcomes: a review of retrospective database cohort studies
.
Eur J Clin Pharmacol
.
2017
Sep
;
73
(
9
):
1055
69
.
[PubMed]
0031-6970
7.
Hogue
AN
,
Temple-Cooper
ME
,
Lagzdins
M
,
Worley
S
,
Scwersenski
J
,
Floyd
R
, et al.
Effects of in-utero exposure to selective serotonin reuptake inhibitors and venlafaxine on term and preterm infants
.
J Neonatal Perinatal Med
.
2017
;
10
(
4
):
371
80
.
[PubMed]
1934-5798
8.
Ferreira
E
,
Carceller
AM
,
Agogué
C
,
Martin
BZ
,
St-André
M
,
Francoeur
D
, et al.
Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates
.
Pediatrics
.
2007
Jan
;
119
(
1
):
52
9
.
[PubMed]
0031-4005
9.
Nörby
U
,
Forsberg
L
,
Wide
K
,
Sjörs
G
,
Winbladh
B
,
Källén
K
.
Neonatal Morbidity After Maternal Use of Antidepressant Drugs During Pregnancy
.
Pediatrics
.
2016
Nov
;
138
(
5
):
e20160181
.
[PubMed]
0031-4005
10.
Levinson-Castiel
R
,
Merlob
P
,
Linder
N
,
Sirota
L
,
Klinger
G
.
Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants
.
Arch Pediatr Adolesc Med
.
2006
Feb
;
160
(
2
):
173
6
.
[PubMed]
1072-4710
11.
Fava
GA
,
Benasi
G
,
Lucente
M
,
Offidani
E
,
Cosci
F
,
Guidi
J
.
Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: systematic Review
.
Psychother Psychosom
.
2018
;
87
(
4
):
195
203
.
[PubMed]
0033-3190
12.
Stroup
DF
,
Berlin
JA
,
Morton
SC
,
Olkin
I
,
Williamson
GD
,
Rennie
D
, et al.
Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group
.
JAMA
.
2000
Apr
;
283
(
15
):
2008
12
.
[PubMed]
0098-7484
13.
Moses-Kolko
EL
,
Bogen
D
,
Perel
J
,
Bregar
A
,
Uhl
K
,
Levin
B
, et al.
Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications
.
JAMA
.
2005
May
;
293
(
19
):
2372
83
.
[PubMed]
0098-7484
14.
Man
KK
,
Chan
EW
,
Ip
P
,
Coghill
D
,
Simonoff
E
,
Chan
PK
, et al.
Prenatal antidepressant exposure and the risk of attention-deficit hyperactivity disorder in children: A systematic review and meta-analysis
.
Neurosci Biobehav Rev
.
2018
Mar
;
86
:
1
11
.
[PubMed]
0149-7634
15.
Warburton
W
,
Hertzman
C
,
Oberlander
TF
.
A register study of the impact of stopping third trimester selective serotonin reuptake inhibitor exposure on neonatal health
.
Acta Psychiatr Scand
.
2010
Jun
;
121
(
6
):
471
9
.
[PubMed]
0001-690X
16.
Concato
J
,
Horwitz
RI
.
Limited usefulness of meta-analysis for informing patient care
.
Psychother Psychosom
.
2019
;
88
(
5
):
257
62
.
[PubMed]
0033-3190
17.
Wells
GA
,
Shea
B
. O’Connell Da, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Oxford;
2000
.
18.
Seehra
J
,
Pandis
N
,
Koletsi
D
,
Fleming
PS
.
Use of quality assessment tools in systematic reviews was varied and inconsistent
.
J Clin Epidemiol
.
2016
Jan
;
69
:
179
84.e5
.
[PubMed]
0895-4356
19.
Iorio
A
,
Spencer
FA
,
Falavigna
M
,
Alba
C
,
Lang
E
,
Burnand
B
, et al.
Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients
.
BMJ
.
2015
Mar
;
350
mar16 7
:
h870
.
[PubMed]
0959-8138
20.
Casey
BM
,
McIntire
DD
,
Leveno
KJ
.
The continuing value of the Apgar score for the assessment of newborn infants
.
N Engl J Med
.
2001
Feb
;
344
(
7
):
467
71
.
[PubMed]
0028-4793
21.
Rücker
G
,
Schwarzer
G
,
Carpenter
J
,
Olkin
I
.
Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells
.
Stat Med
.
2009
Feb
;
28
(
5
):
721
38
.
[PubMed]
0277-6715
22.
Higgins
JP
,
Thomas
J
,
Chandler
J
,
Cumpston
M
,
Li
T
,
Page
MJ
, et al.
Cochrane handbook for systematic reviews of interventions.
Hoboken: John Wiley & Sons;
2019
Sep.
23.
DerSimonian
R
,
Laird
N
.
Meta-analysis in clinical trials
.
Control Clin Trials
.
1986
Sep
;
7
(
3
):
177
88
.
[PubMed]
0197-2456
24.
Egger
M
,
Davey Smith
G
,
Schneider
M
,
Minder
C
.
Bias in meta-analysis detected by a simple, graphical test
.
BMJ
.
1997
Sep
;
315
(
7109
):
629
34
.
[PubMed]
0959-8138
25.
Begg
CB
,
Mazumdar
M
.
Operating characteristics of a rank correlation test for publication bias
.
Biometrics
.
1994
Dec
;
50
(
4
):
1088
101
.
[PubMed]
0006-341X
26.
Costei
AM
,
Kozer
E
,
Ho
T
,
Ito
S
,
Koren
G
.
Perinatal outcome following third trimester exposure to paroxetine
.
Arch Pediatr Adolesc Med
.
2002
Nov
;
156
(
11
):
1129
32
.
[PubMed]
1072-4710
27.
Wisner
KL
,
Sit
DK
,
Hanusa
BH
,
Moses-Kolko
EL
,
Bogen
DL
,
Hunker
DF
, et al.
Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes
.
Am J Psychiatry
.
2009
May
;
166
(
5
):
557
66
.
[PubMed]
0002-953X
28.
Davidson
S
,
Prokonov
D
,
Taler
M
,
Maayan
R
,
Harell
D
,
Gil-Ad
I
, et al.
Effect of exposure to selective serotonin reuptake inhibitors in utero on fetal growth: potential role for the IGF-I and HPA axes
.
Pediatr Res
.
2009
Feb
;
65
(
2
):
236
41
.
[PubMed]
0031-3998
29.
Malm
H
,
Klaukka
T
,
Neuvonen
PJ
.
Risks associated with selective serotonin reuptake inhibitors in pregnancy
.
Obstet Gynecol
.
2005
Dec
;
106
(
6
):
1289
96
.
[PubMed]
0029-7844
30.
Chambers
CD
,
Johnson
KA
,
Dick
LM
,
Felix
RJ
,
Jones
KL
.
Birth outcomes in pregnant women taking fluoxetine
.
N Engl J Med
.
1996
Oct
;
335
(
14
):
1010
5
.
[PubMed]
0028-4793
31.
Pawluski
JL
,
Galea
LA
,
Brain
U
,
Papsdorf
M
,
Oberlander
TF
.
Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors
.
Pediatrics
.
2009
Oct
;
124
(
4
):
e662
70
.
[PubMed]
0031-4005
32.
Oberlander
TF
,
Bonaguro
RJ
,
Misri
S
,
Papsdorf
M
,
Ross
CJ
,
Simpson
EM
.
Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications
.
Mol Psychiatry
.
2008
Jan
;
13
(
1
):
65
73
.
[PubMed]
1359-4184
33.
Jordan
AE
,
Jackson
GL
,
Deardorff
D
,
Shivakumar
G
,
McIntire
DD
,
Dashe
JS
.
Serotonin reuptake inhibitor use in pregnancy and the neonatal behavioral syndrome
.
J Matern Fetal Neonatal Med
.
2008
Oct
;
21
(
10
):
745
51
.
[PubMed]
1476-7058
34.
Oberlander
TF
,
Warburton
W
,
Misri
S
,
Aghajanian
J
,
Hertzman
C
.
Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study
.
Br J Psychiatry
.
2008
May
;
192
(
5
):
338
43
.
[PubMed]
0007-1250
35.
Grigoriadis
S
,
VonderPorten
EH
,
Mamisashvili
L
,
Eady
A
,
Tomlinson
G
,
Dennis
CL
, et al.
The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis
.
J Clin Psychiatry
.
2013
Apr
;
74
(
4
):
e309
20
.
[PubMed]
0160-6689
36.
Kieviet
N
,
van Keulen
V
,
van de Ven
PM
,
Dolman
KM
,
Deckers
M
,
Honig
A
.
Serotonin and poor neonatal adaptation after antidepressant exposure in utero
.
Acta Neuropsychiatr
.
2017
Feb
;
29
(
1
):
43
53
.
[PubMed]
0924-2708
37.
Sivojelezova
A
,
Shuhaiber
S
,
Sarkissian
L
,
Einarson
A
,
Koren
G
.
Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome
.
Am J Obstet Gynecol
.
2005
Dec
;
193
(
6
):
2004
9
.
[PubMed]
0002-9378
38.
O’Connor
AB
,
O’Brien
L
,
Alto
WA
,
Wong
J
.
Does concurrent in utero exposure to buprenorphine and antidepressant medications influence the course of neonatal abstinence syndrome?
J Matern Fetal Neonatal Med
.
2016
;
29
(
1
):
112
4
.
[PubMed]
1476-7058
39.
Klinger
G
,
Frankenthal
D
,
Merlob
P
,
Diamond
G
,
Sirota
L
,
Levinson-Castiel
R
, et al.
Long-term outcome following selective serotonin reuptake inhibitor induced neonatal abstinence syndrome
.
J Perinatol
.
2011
Sep
;
31
(
9
):
615
20
.
[PubMed]
0743-8346
40.
Favrelière
S
,
Nourrisson
A
,
Jaafari
N
,
Pérault Pochat
MC
.
[Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn]
.
Encephale
.
2010
Jun
;
36
Suppl 2
:
D133
8
.
[PubMed]
0013-7006
41.
Gentile
S
.
On categorizing gestational, birth, and neonatal complications following late pregnancy exposure to antidepressants: the prenatal antidepressant exposure syndrome
.
CNS Spectr
.
2010
Mar
;
15
(
3
):
167
85
.
[PubMed]
1092-8529
42.
Oberlander
TF
,
Misri
S
,
Fitzgerald
CE
,
Kostaras
X
,
Rurak
D
,
Riggs
W
.
Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure
.
J Clin Psychiatry
.
2004
Feb
;
65
(
2
):
230
7
.
[PubMed]
0160-6689
43.
Sanz
EJ
,
De-las-Cuevas
C
,
Kiuru
A
,
Bate
A
,
Edwards
R
.
Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis
.
Lancet
.
2005
Feb
;
365
(
9458
):
482
7
.
[PubMed]
0140-6736
44.
Reuter
S
,
Moser
C
,
Baack
M
.
Respiratory distress in the newborn
.
Pediatr Rev
.
2014
Oct
;
35
(
10
):
417
28
.
[PubMed]
0191-9601
45.
Sperling
M
. Hypoglycaemia.
Nelson Textbook of Pediatrics
.
Philadelphia
:
Saunders
;
2007
. pp.
655
69
.
46.
Récalt
AM
,
Cohen
D
.
Withdrawal Confounding in Randomized Controlled Trials of Antipsychotic, Antidepressant, and Stimulant Drugs, 2000-2017
.
Psychother Psychosom
.
2019
;
88
(
2
):
105
13
.
[PubMed]
0033-3190
47.
Baldessarini
RJ
,
Tondo
L
.
Effects of Treatment Discontinuation in Clinical Psychopharmacology
.
Psychother Psychosom
.
2019
;
88
(
2
):
65
70
.
[PubMed]
0033-3190
48.
Cosci
F
,
Mansueto
G
,
Fava
GA
.
Relapse prevention in recurrent major depressive disorder. A comparison of different treatment options based on clinical experience and a critical review of the literature
.
Int J Psychiatry Clin Pract
.
2020
Nov
;
24
(
4
):
341
8
.
[PubMed]
1365-1501
49.
Carvalho
AF
,
Sharma
MS
,
Brunoni
AR
,
Vieta
E
,
Fava
GA
.
The safety, tolerability and risks associated with the use of newer generation antidepressant drugs
.
Psychother Psychosom
.
2016
;
85
(
5
):
270
88
.
[PubMed]
0033-3190
50.
Sujan
AC
,
Rickert
ME
,
Öberg
AS
,
Quinn
PD
,
Hernández-Díaz
S
,
Almqvist
C
, et al.
Associations of Maternal Antidepressant Use During the First Trimester of Pregnancy With Preterm Birth, Small for Gestational Age, Autism Spectrum Disorder, and Attention-Deficit/Hyperactivity Disorder in Offspring
.
JAMA
.
2017
Apr
;
317
(
15
):
1553
62
.
[PubMed]
0098-7484
51.
Smith
B
,
Dubovsky
SL
.
Pharmacotherapy of mood disorders and psychosis in pre- and post-natal women
.
Expert Opin Pharmacother
.
2017
Nov
;
18
(
16
):
1703
19
.
[PubMed]
1465-6566
52.
Molenaar
NM
,
Brouwer
ME
,
Burger
H
,
Kamperman
AM
,
Bergink
V
,
Hoogendijk
WJG
, et al.
Preventive Cognitive Therapy with antidepressant discontinuation during pregnancy: results from a randomized controlled trial. J Clin Psychiatry.
2020
Jun
;81(4):19l13099.
53.
Guidi
J
,
Fava
GA
.
Sequential combination of pharmacotherapy and psychotherapy in major depressive disorder: a systematic review and meta-analysis
.
JAMA Psychiatry
.
2021
Mar
;
78
(
3
):
261
9
.
[PubMed]
2168-622X
54.
Cosci
F
,
Guidi
J
,
Mansueto
G
,
Fava
GA
.
Psychotherapy in recurrent depression: efficacy, pitfalls, and recommendations
.
Expert Rev Neurother
.
2020
Nov
;
20
(
11
):
1169
75
.
[PubMed]
1473-7175
55.
Richardson
WS
,
Doster
LM
.
Comorbidity and multimorbidity need to be placed in the context of a framework of risk, responsiveness, and vulnerability
.
J Clin Epidemiol
.
2014
Mar
;
67
(
3
):
244
6
.
[PubMed]
0895-4356
56.
Rush
AJ
,
Trivedi
MH
,
Wisniewski
SR
,
Nierenberg
AA
,
Stewart
JW
,
Warden
D
, et al.
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report
.
Am J Psychiatry
.
2006
Nov
;
163
(
11
):
1905
17
.
[PubMed]
0002-953X
57.
Fava
GA
,
Rafanelli
C
.
Iatrogenic factors in psychopathology
.
Psychother Psychosom
.
2019
;
88
(
3
):
129
40
.
[PubMed]
0033-3190
58.
Traylor
CS
,
Johnson
JD
,
Kimmel
MC
,
Manuck
TA
.
Effects of psychological stress on adverse pregnancy outcomes and nonpharmacologic approaches for reduction: an expert review
.
Am J Obstet Gynecol MFM
.
2020
Nov
;
2
(
4
):
100229
.
[PubMed]
2589-9333
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.